Liberty Health Sciences Introduces HONEY Vape Products
TORONTO, June 19, 2020 /CNW/ - Liberty Health Sciences Inc. (CSE: LHS) (OTCQX: LHSIF) www.libertyhealthsciences.com ("Liberty" or the "Company"), a provider of high quality cannabis, announced today that it has entered into a licensing agreement with licensed California adult use and medicinal cannabis company HONEY®, one of California's largest full service companies, to supply all of Liberty's dispensaries with the company's full assortment of branded products.
In 2012 HONEY® revolutionized the cannabis industry by becoming the first producer in the world to market distilled cannabis oil in vape cartridges. Today, they provide authentic, full spectrum oil in vape cartridges, applicators, and caps to legal dispensaries and delivery services.
"We are excited to partner with HONEY®, a longstanding pioneer and premium brand in the cannabis space," said Victor Mancebo, Chief Executive Officer of Liberty. "Adding HONEY® to our portfolio of brands creates an immediate distinction between other competitors in the space and reinforces our product offering strategy to provide variety, quality, and price versatility in all of the products we market."
All THC and CBD oil in HONEY cartridges are free of fillers and are lab tested to be 75% +/- cannabinoids. The devices provide the full range of benefits and deliver the precise dosage of cannabinoids with every use.
"We are very excited to be partnering with Liberty to introduce our HONEY® products to the Florida medicinal cannabis market as we started in the California medical market nearly a decade ago," said Peter Tejera, Chief Executive Officer of HONEY®. "We look forward to growing our in-dispensary presence in Florida and this partnership will provide Floridian consumers with a superior choice of high quality, predictable, and consistent product experience second to none."
Patients may place an order online at www.libertyhealthsciences.com for in-store pick-up or delivery.
About Liberty Health Sciences Inc.
Liberty is the cannabis provider committed to providing a trusted, high quality cannabis experience based on our genuine care for all cannabis users and a focus on operational excellence from seed to sale. Liberty's measured approach to expansion opportunities is focused on maximizing returns to shareholders, while keeping consumers' well-being at the forefront of what we do. For more information, please visit: www.libertyhealthsciences.com.
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS: This press release contains certain forward-looking statements within the meaning of applicable securities laws. Any statements that are contained in this news release that are not statements of historical fact may be deemed to be forward-looking statements. Forward-looking statements are often identified by terms such as "may", "should", "anticipate", "expect", "believe", "plan", "intend" or the negative of these terms and similar expressions. Forward-looking statements in this news release include, but are not limited to, expectations related to the Company's production capabilities, expectations concerning the receipt of all necessary approvals from the Florida Department of Health, expectations concerning the opening of new dispensaries and the expansion of its greenhouse space, and the Company's future expansion and growth strategies. Forward-looking statements necessarily involve known and unknown risks, including, without limitation, risks associated with general economic conditions; adverse industry events; marketing costs; loss of markets; future legislative and regulatory developments involving medical marijuana; inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favorable terms; the medical marijuana industry in the United States generally, income tax and regulatory matters; the ability of Liberty to implement its business strategies; competition; crop failure; currency and interest rate fluctuations and other risks. Readers are cautioned that the foregoing list is not exhaustive. Readers are further cautioned not to place undue reliance on forward-looking statements as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement.
SOURCE Liberty Health Sciences Inc.
Media Contacts: Dwain Schenck, (203) 223-5230, [email protected]; Victor Mancebo, Chief Executive Officer, (352) 388-3178, [email protected]
Share this article